This section contains statements of recommendations that are intended to optimize patient care and are informed by a systematic review of evidence and an assessment of the benefits and harms of alternative care options.
The growing number of oral medications for the treatment of cancer over the past decade has revolutionized oncology care, providing many new options for cancer treatment. HOPA recognizes these new options also create common practice challenges. The following are practice tools, standards, and guidelines that HOPA recommends for use in the management of oral chemotherapy.
Learn more about Oral Chemotherapy Resources. (PDF)
Learn more about immune checkpoint inhibitor toxicity management.
Learn more about NCCN Apps.